trending Market Intelligence /marketintelligence/en/news-insights/trending/qjabpjae-roz1kemaagzlw2 content esgSubNav
In This List

Essa Pharma regains Nasdaq compliance

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Essa Pharma regains Nasdaq compliance

Essa Pharma Inc. regained compliance with the Nasdaq Stock Market's minimum market value listing requirement.

The Canadian pharmaceutical company recently completed a reverse stock split to meet Nasdaq's $1 minimum required bid price.